Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
A	AGILENT TECHNOLOGIES INC	$32.63B	19.70%	10.30%	14.57%	21.40%	0.86	2.07	52.20%	18.30%	21.81%
SNY	SANOFI	$116.80B	10.50%	6.00%	9.57%	20.60%	0.77	1.09	72.10%	16.70%	20.16%
REGN	REGENERON PHARMACEUTICALS INC	$80.54B	14.80%	11.50%	14.57%	15.60%	0.30	4.13	85.40%	31.40%	36.77%
BLFS	BIOLIFE SOLUTIONS INC	$942.33M	-1.30%	-1.20%	-1.89%	-5.50%	0.09	5.94	64.60%	-4.80%	-7.54%
AMN	AMN HEALTHCARE SERVICES INC	$703.27M	-14.70%	-4.30%	-3.66%	-4.20%	2.26	0.94	28.30%	-3.50%	-2.03%
TVTX	TRAVERE THERAPEUTICS INC	$2.81B	-40.20%	-4.50%	-3.10%	-2.40%	4.27	2.74	97.90%	-5.20%	-2.81%
DXCM	DEXCOM INC	$23.95B	32.40%	12.00%	26.37%	22.40%	1.31	1.88	60.10%	17.90%	23.74%
HLN	HALEON PLC	$44.45B	10.20%	5.00%	8.67%	24.40%	0.98	0.92	64.20%	15.10%	21.77%
ATEC	ALPHATEC HOLDINGS INC	$1.64B	N/A	-18.20%	-17.04%	-11.30%	62.67	2.06	69.60%	-18.80%	-12.76%
OFIX	ORTHOFIX MEDICAL INC	$462.86M	-20.40%	-11.00%	-10.78%	-14.30%	0.89	2.45	68.80%	-11.20%	-8.92%
CAI	CARIS LIFE SCIENCES INC	$5.45B	N/A	-64.10%	-1.13%	-2.20%	0.95	7.85	66.40%	-66.20%	-1.38%
MASS	908 DEVICES INC	$247.08M	13.30%	10.10%	12.45%	32.60%	0.32	4.24	50.60%	34.70%	34.56%
HNGE	HINGE HEALTH INC	$3.07B	-672.70%	-58.10%	-137.90%	-535.10%	2.05	1.47	79.60%	-72.10%	-89.69%
XLO	XILIO THERAPEUTICS INC	$49.21M	-311.80%	-26.60%	-35.60%	119.70%	3.39	2.58	100.00%	-80.10%	-80.05%
INCY	INCYTE CORP	$19.09B	29.10%	20.70%	30.63%	77.30%	0.35	3.32	92.80%	25.00%	32.42%
EW	EDWARDS LIFESCIENCES CORP	$47.01B	10.40%	8.00%	11.03%	19.90%	0.33	3.72	78.00%	17.70%	21.60%
MCK	MCKESSON CORP	$108.31B	-245.30%	5.30%	34.95%	88.90%	-65.56	0.88	3.60%	1.10%	1.41%
CPRX	CATALYST PHARMACEUTICALS INC	$3.02B	24.30%	21.20%	29.63%	308.40%	0.16	6.08	85.20%	36.40%	48.14%
ONC	BEONE MEDICINES LTD	$34.51B	7.30%	4.10%	7.47%	16.70%	0.88	3.41	87.50%	5.40%	8.89%
RVTY	REVVITY INC	$9.94B	3.20%	2.00%	3.30%	7.80%	0.68	1.68	54.80%	8.40%	12.53%
STTK	SHATTUCK LABS INC	$459.44M	-65.00%	-58.60%	-58.12%	-181.80%	0.11	11.70	100.00%	-4,880.90%	-4,880.90%
NAGE	NIAGEN BIOSCIENCE INC	$350.75M	26.10%	18.40%	21.03%	138.30%	0.39	4.86	64.30%	13.40%	14.06%
CI	CIGNA GROUP	$71.16B	14.50%	3.90%	8.72%	17.80%	2.78	0.85	9.30%	2.20%	3.22%
BNR	BURNING ROCK BIOTECH LTD	$169.73M	-10.00%	-6.70%	-9.38%	-35.60%	0.53	2.99	74.70%	-10.30%	-9.96%
ENSG	ENSIGN GROUP INC	$11.43B	16.60%	6.80%	10.14%	7.90%	1.45	1.42	15.80%	6.80%	9.16%
PRPO	PRECIPIO INC	$45.31M	-2.80%	-1.80%	-1.65%	-5.30%	0.46	1.61	44.50%	-1.50%	-1.21%
ALC	ALCON INC	$36.34B	4.40%	3.10%	4.78%	9.70%	0.43	2.12	55.20%	9.40%	13.11%
IRTC	IRHYTHM HOLDINGS INC	$3.77B	-38.30%	-4.60%	-3.51%	-2.40%	5.68	4.63	70.60%	-6.00%	-4.07%
AVNS	AVANOS MEDICAL INC	$648.72M	-9.20%	-6.80%	-6.43%	-12.80%	0.38	2.15	50.50%	-10.40%	-8.33%
ADMA	ADMA BIOLOGICS INC	$2.19B	35.00%	26.00%	34.21%	38.40%	0.31	6.71	57.40%	28.80%	37.20%
IQV	IQVIA HOLDINGS INC	$29.40B	22.30%	4.70%	10.83%	17.10%	3.59	0.75	33.30%	8.30%	14.35%
MDT	MEDTRONIC PLC	$111.22B	9.50%	5.00%	7.62%	11.40%	0.86	2.54	64.90%	13.00%	17.61%
PNTG	PENNANT GROUP INC	$1.03B	9.30%	3.70%	5.86%	6.70%	1.79	1.14	13.80%	3.10%	5.08%
PODD	INSULET CORP	$14.38B	17.40%	7.50%	15.89%	14.60%	1.11	2.81	71.60%	9.10%	14.73%
DHR	DANAHER CORP	$135.15B	7.00%	4.50%	5.89%	16.20%	0.59	1.87	59.10%	14.70%	18.37%
HCSG	HEALTHCARE SERVICES GROUP INC	$1.29B	11.80%	7.30%	11.13%	16.10%	0.56	3.38	13.00%	3.20%	3.78%
VCEL	VERICEL CORP	$1.73B	5.20%	3.70%	4.10%	4.40%	0.38	5.03	74.40%	6.00%	6.52%
ETON	ETON PHARMACEUTICALS INC	$681.84M	-18.80%	-4.80%	-1.57%	-2.70%	2.52	1.57	53.90%	-5.70%	-1.04%
COLL	COLLEGIUM PHARMACEUTICAL INC	$1.03B	24.10%	3.90%	14.38%	19.10%	4.49	1.57	59.30%	8.10%	22.41%
DH	DEFINITIVE HEALTHCARE CORP	$155.42M	-46.60%	-18.10%	-23.78%	-69.80%	1.27	1.64	75.90%	-57.50%	-56.97%
ICUI	ICU MEDICAL INC	$3.04B	0.00%	0.00%	2.43%	3.40%	0.91	2.39	36.80%	0.00%	3.86%
EHC	ENCOMPASS HEALTH CORP	$9.68B	24.50%	8.30%	14.11%	12.60%	1.56	1.08	27.20%	9.50%	14.87%
TARS	TARSUS PHARMACEUTICALS INC	$2.98B	-19.60%	-12.70%	-13.00%	-16.40%	0.64	3.85	93.20%	-14.70%	-12.28%
SIBN	SI-BONE INC	$579.45M	-11.00%	-8.10%	-7.63%	-7.80%	0.34	8.55	79.60%	-9.40%	-8.10%
MEDP	MEDPACE HOLDINGS INC	$14.14B	118.80%	25.10%	83.83%	-157.70%	3.30	0.74	30.10%	17.80%	20.93%
LQDA	LIQUIDIA CORP	$3.32B	-209.30%	-25.30%	-23.29%	-24.60%	6.33	2.01	91.60%	-43.50%	-28.27%
SCYX	SCYNEXIS INC	$39.66M	-19.00%	-14.40%	-15.83%	-21.20%	0.20	7.04	100.00%	-41.80%	-40.95%
QDEL	QUIDELORTHO CORP	$1.17B	-46.40%	-18.60%	-19.36%	-19.60%	2.00	1.50	46.70%	-41.50%	-34.07%
SLNO	SOLENO THERAPEUTICS INC	$2.04B	5.80%	4.50%	5.25%	7.60%	0.25	5.80	98.60%	10.80%	13.85%
SLP	SIMULATIONS PLUS INC	$241.56M	-45.50%	-42.40%	-53.87%	-275.60%	0.08	5.62	59.60%	-81.70%	-87.29%
ALNY	ALNYLAM PHARMACEUTICALS INC	$42.29B	90.30%	6.70%	16.45%	11.30%	5.29	2.76	81.60%	8.40%	15.50%
BMRN	BIOMARIN PHARMACEUTICAL INC	$10.67B	5.80%	4.70%	7.22%	8.70%	0.25	5.21	77.70%	10.80%	15.32%
HQY	HEALTHEQUITY INC	$7.15B	10.10%	6.30%	10.38%	27.20%	0.60	3.27	69.50%	16.40%	25.47%
VEEV	VEEVA SYSTEMS INC	$28.42B	13.40%	11.10%	16.27%	25.10%	0.25	4.89	75.50%	28.40%	37.38%
ZVRA	ZEVRA THERAPEUTICS INC	$551.89M	74.60%	33.80%	38.56%	47.10%	0.84	5.68	84.50%	78.20%	88.90%
XOMA	XOMA ROYALTY CORP	$392.65M	22.50%	7.60%	13.31%	14.80%	2.01	3.37	100.00%	35.50%	60.69%
GEHC	GE HEALTHCARE TECHNOLOGIES INC	$32.06B	21.20%	5.90%	11.29%	18.10%	2.54	1.37	40.00%	10.10%	15.21%
BLCO	BAUSCH & LOMB CORP	$5.84B	-5.60%	-2.60%	0.79%	1.10%	1.16	1.55	59.80%	-7.10%	1.88%
OMER	OMEROS CORP	$784.76M	N/A	-1.40%	-0.93%	-0.40%	-3.69	2.76	N/A	N/A	N/A
ENTA	ENANTA PHARMACEUTICALS INC	$381.31M	-78.60%	-23.20%	-22.46%	-23.10%	1.60	4.44	100.00%	-106.80%	-95.48%
PARK	PARK DENTAL PARTNERS INC	$80.44M	-4.10%	-0.20%	0.18%	0.20%	7.17	1.06	13.80%	-0.10%	0.10%
PHG	KONINKLIJKE PHILIPS NV	$26.10B	7.80%	3.20%	7.84%	11.90%	1.46	1.32	45.20%	5.00%	8.54%
AXSM	AXSOME THERAPEUTICS INC	$8.62B	-254.10%	-28.20%	-56.97%	-108.20%	6.81	1.56	92.60%	-28.70%	-27.74%
DGX	QUEST DIAGNOSTICS INC	$21.76B	13.90%	6.20%	11.26%	16.40%	1.26	1.04	33.20%	9.00%	14.23%
IBRX	IMMUNITYBIO INC	$7.51B	N/A	-81.40%	-54.30%	-21.40%	-2.00	5.10	99.30%	-310.20%	-210.97%
AZN	ASTRAZENECA PLC	$315.59B	22.70%	9.10%	16.88%	30.60%	1.34	0.94	81.90%	17.40%	23.98%
LCTX	LINEAGE CELL THERAPEUTICS INC	$391.07M	-131.00%	-62.80%	-67.99%	-1,983.10%	1.55	5.20	99.00%	-436.50%	-472.75%
ZBH	ZIMMER BIOMET HOLDINGS INC	$17.78B	5.60%	3.10%	5.48%	8.80%	0.82	1.98	69.70%	8.60%	13.65%
RIGL	RIGEL PHARMACEUTICALS INC	$508.57M	240.80%	128.90%	31.17%	70.00%	0.31	2.42	93.30%	124.70%	43.89%
NTRA	NATERA INC	$29.48B	-15.30%	-10.80%	-13.49%	-47.60%	0.40	3.39	64.70%	-9.00%	-11.45%
APYX	APYX MEDICAL CORP	$153.93M	-117.50%	-18.50%	-9.71%	-9.00%	3.58	5.00	62.50%	-21.20%	-10.13%
STVN	STEVANATO GROUP SPA	$4.16B	9.70%	5.80%	10.55%	9.80%	0.71	1.76	29.00%	11.80%	17.85%
TECH	BIO-TECHNE CORP	$8.31B	4.10%	3.20%	5.15%	9.40%	0.25	4.54	65.20%	6.70%	10.09%
ESTA	ESTABLISHMENT LABS HOLDINGS INC	$1.71B	-201.80%	-15.00%	-11.91%	-7.80%	14.17	3.04	69.30%	-24.20%	-15.52%
TXG	10X GENOMICS INC	$2.85B	-5.70%	-4.40%	-4.49%	-8.30%	0.31	4.46	69.10%	-6.80%	-6.21%
DERM	JOURNEY MEDICAL CORP	$135.29M	-46.40%	-13.20%	-13.43%	-37.40%	1.97	1.79	66.20%	-18.50%	-12.40%
COR	CENCORA INC	$63.18B	101.40%	2.20%	13.87%	40.80%	39.96	0.92	3.70%	0.50%	0.82%
NPCE	NEUROPACE INC	$493.22M	-105.70%	-20.00%	-15.96%	-10.10%	4.55	5.28	77.20%	-21.50%	-14.01%
NRXP	NRX PHARMACEUTICALS INC	$72.75M	N/A	-283.50%	178.92%	110.80%	-1.81	0.31	58.80%	-2,336.50%	-2,281.71%
BFLY	BUTTERFLY NETWORK INC	$1.05B	-35.30%	-25.30%	-32.61%	-65.60%	0.51	3.83	46.90%	-79.00%	-77.31%
PGNY	PROGYNY INC	$1.36B	11.40%	7.70%	17.67%	22.90%	0.44	2.73	23.60%	4.50%	7.41%
HSDT	SOLANA CO	$102.36M	-105.00%	-20.70%	-13.38%	-25.10%	0.01	10.33	91.70%	-679.60%	-669.02%
INSP	INSPIRE MEDICAL SYSTEMS INC	$1.57B	21.10%	17.90%	8.12%	10.00%	0.16	6.08	85.40%	15.90%	7.22%
SNWV	SANUWAVE HEALTH INC	$145.24M	-141.60%	34.50%	93.07%	267.50%	22.07	1.38	77.10%	26.80%	41.19%
AORT	ARTIVION INC	$1.64B	2.40%	1.20%	5.28%	7.00%	0.97	3.53	64.40%	2.20%	9.37%
ADCT	ADC THERAPEUTICS SA	$480.23M	N/A	-47.30%	-35.57%	-77.00%	-2.74	4.37	92.90%	-175.30%	-110.59%
KNSA	KINIKSA PHARMACEUTICALS INTERNATIONAL PLC	$3.74B	11.50%	8.60%	14.23%	23.00%	0.35	3.79	88.50%	8.70%	13.12%
TOI	ONCOLOGY INSTITUTE INC	$308.38M	N/A	-37.20%	-52.79%	-33.30%	-11.47	1.59	15.20%	-12.10%	-9.84%
ALHC	ALIGNMENT HEALTHCARE INC	$3.83B	-0.50%	-0.10%	2.97%	6.20%	4.95	1.71	12.40%	0.00%	0.38%
CRL	CHARLES RIVER LABORATORIES INTERNATIONAL INC	$8.56B	-4.40%	-1.90%	0.09%	0.10%	1.24	1.29	33.00%	-3.60%	0.13%
UHS	UNIVERSAL HEALTH SERVICES INC	$10.79B	21.10%	9.80%	17.14%	15.70%	1.13	1.05	43.00%	8.60%	12.13%
LH	LABCORP HOLDINGS INC	$22.55B	10.30%	4.80%	8.55%	11.70%	1.13	1.42	28.80%	6.30%	9.54%
LFCR	LIFECORE BIOMEDICAL INC	$143.91M	N/A	N/A	N/A	N/A	-13.95	3.49	N/A	N/A	N/A
RMD	RESMED INC	$32.65B	24.80%	18.30%	24.80%	56.30%	0.35	3.06	60.90%	27.50%	33.34%
HTFL	HEARTFLOW INC	$2.13B	N/A	-43.80%	-32.07%	-48.60%	0.20	5.20	76.80%	-66.30%	-57.77%
FBIO	FORTRESS BIOTECH INC	$83.73M	-4.40%	-1.10%	12.00%	22.00%	2.47	2.49	66.90%	-3.00%	25.77%
AMGN	AMGEN INC	$187.56B	96.70%	8.60%	18.02%	16.50%	9.46	1.14	67.20%	21.00%	31.92%
BDSX	BIODESIX INC	$148.57M	-1,760.80%	-40.30%	-39.33%	-26.60%	-36.49	1.87	81.10%	-39.80%	-31.13%
NBP	NOVABRIDGE BIOSCIENCES	$280.30M	-11.50%	-10.80%	-9.39%	-26.90%	0.07	14.47	N/A	N/A	N/A
HALO	HALOZYME THERAPEUTICS INC	$7.61B	92.70%	14.10%	20.65%	20.10%	50.73	4.66	83.60%	22.70%	34.73%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	606	-0.01%	+3.43%	-0.16%	-29.10%	28.69x	4.77x	-38.36%	-14.24%	-8.58%	+63.52%	Strong Buy
Diagnostics & Research	55	+0.31%	+1.69%	-3.45%	+10.47%	20.41x	3.69x	-2.71%	+6.61%	+12.95%	+25.93%	Strong Buy
Drug Manufacturers - General	20	-1.34%	+2.11%	-6.55%	+20.55%	32.72x	7.01x	+10.22%	+12.41%	+21.10%	+19.20%	Buy
Drug Manufacturers - Specialty & Generic	75	-1.19%	+0.83%	-6.28%	-27.18%	-196.18x	1.63x	+9.19%	+2.51%	+7.27%	+43.81%	Strong Buy
Healthcare Plans	10	+1.24%	+1.76%	-5.45%	-36.04%	22.78x	1.80x	+9.09%	+2.85%	+6.97%	+25.73%	Buy
Health Information Services	55	+0.55%	-0.27%	-8.49%	-80.30%	23.49x	2.80x	-7.72%	+2.33%	+4.64%	+61.04%	Buy
Medical Care Facilities	50	-0.22%	-1.38%	-10.26%	-42.38%	18.03x	5.29x	-68.62%	+7.35%	+19.11%	+25.02%	Buy
Medical Devices	137	-0.07%	-1.18%	-9.86%	-66.48%	23.94x	3.27x	+8.46%	+5.25%	+9.40%	+54.60%	Strong Buy
Medical Distribution	10	+1.45%	+2.26%	-10.46%	+25.96%	29.76x	317.88x	-99.39%	+3.30%	+23.34%	+14.03%	Strong Buy
Medical Instruments & Supplies	57	-0.61%	+0.07%	-7.92%	-10.20%	-490.95x	3.36x	+9.37%	+7.41%	+4.05%	+32.85%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Apr 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Bioventus (NASDAQ:BVS)

Bioventus (NASDAQ:BVS) is the #1 top healthcare stock out of 1075 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Bioventus (NASDAQ:BVS) is: Value: B, Growth: A, Momentum: C, Sentiment: C, Safety: B, Financials: A, and AI: C.

Bioventus (NASDAQ:BVS) has a Due Diligence Score of 44, which is 17 points higher than the healthcare sector average of 27. It passed 14 out of 33 due diligence checks and has strong fundamentals. Bioventus has seen its stock lose -5.68% over the past year, overperforming other healthcare stocks by 30 percentage points.

Bioventus has an average 1 year price target of $15.00, an upside of 67.22% from Bioventus's current stock price of $8.97.

Bioventus stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Bioventus, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Amneal Pharmaceuticals (NASDAQ:AMRX)

Amneal Pharmaceuticals (NASDAQ:AMRX) is the #2 top healthcare stock out of 1075 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Amneal Pharmaceuticals (NASDAQ:AMRX) is: Value: B, Growth: A, Momentum: B, Sentiment: B, Safety: C, Financials: C, and AI: C.

Amneal Pharmaceuticals (NASDAQ:AMRX) has a Due Diligence Score of 35, which is 8 points higher than the healthcare sector average of 27. It passed 11 out of 33 due diligence checks and has average fundamentals. Amneal Pharmaceuticals has seen its stock return 52.75% over the past year, overperforming other healthcare stocks by 88 percentage points.

Amneal Pharmaceuticals has an average 1 year price target of $15.00, an upside of 20.19% from Amneal Pharmaceuticals's current stock price of $12.48.

Amneal Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Amneal Pharmaceuticals, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Aveanna Healthcare Holdings (NASDAQ:AVAH)

Aveanna Healthcare Holdings (NASDAQ:AVAH) is the #3 top healthcare stock out of 1075 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Aveanna Healthcare Holdings (NASDAQ:AVAH) is: Value: A, Growth: B, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Aveanna Healthcare Holdings (NASDAQ:AVAH) has a Due Diligence Score of 32, which is 5 points higher than the healthcare sector average of 27. It passed 11 out of 33 due diligence checks and has average fundamentals. Aveanna Healthcare Holdings has seen its stock return 13.52% over the past year, overperforming other healthcare stocks by 49 percentage points.

Aveanna Healthcare Holdings has an average 1 year price target of $10.00, an upside of 56.74% from Aveanna Healthcare Holdings's current stock price of $6.38.

Aveanna Healthcare Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Aveanna Healthcare Holdings, 33.33% have issued a Strong Buy rating, 16.67% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 72 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Novabay Pharmaceuticals (NYSEMKT:NBY)

Novabay Pharmaceuticals (NYSEMKT:NBY) has an annual dividend yield of 205.13%, which is 200 percentage points higher than the healthcare sector average of 4.92%.

Novabay Pharmaceuticals's dividend payout ratio of -105.3% indicates that its high dividend yield might not be sustainable for the long-term.

2. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 24.18%, which is 19 percentage points higher than the healthcare sector average of 4.92%.

Dominari Holdings's dividend payout ratio of -42.4% indicates that its high dividend yield might not be sustainable for the long-term.

3. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 11.23%, which is 6 percentage points higher than the healthcare sector average of 4.92%. Spok Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 162.3% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.05% in the last day, and up 1.62% over the last week. Lipocine was the among the top losers in the healthcare sector, dropping -77.84% yesterday.

Lipocine shares are trading lower after the company's LPCN 1154 missed its Phase 3 primary endpoint in postpartum depression.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 86, which is 70 points higher than the healthcare sector average of 16. It passed 6 out of 7 valuation due diligence checks.

Embecta's stock has dropped -29.31% in the past year. It has overperformed other stocks in the healthcare sector by 6 percentage points.

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 57, which is 41 points higher than the healthcare sector average of 16. It passed 4 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has gained 145.83% in the past year. It has overperformed other stocks in the healthcare sector by 181 percentage points.

3. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 55 points higher than the healthcare sector average of 16. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -14.72% in the past year. It has overperformed other stocks in the healthcare sector by 21 percentage points.

Are healthcare stocks a good buy now?

58.29% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 44.05% over the next year.

5.73% of healthcare stocks have a Zen Rating of A (Strong Buy), 12.7% of healthcare stocks are rated B (Buy), 50.93% are rated C (Hold), 23.91% are rated D (Sell), and 6.72% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is -8.01x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bioventus (NASDAQ:BVS)

2. Amneal Pharmaceuticals (NASDAQ:AMRX)

3. Aveanna Healthcare Holdings (NASDAQ:AVAH)

1. Novabay Pharmaceuticals (NYSEMKT:NBY)

2. Dominari Holdings (NASDAQ:DOMH)

3. Spok Holdings (NASDAQ:SPOK)

1. Embecta (NASDAQ:EMBC)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Harmony Biosciences Holdings (NASDAQ:HRMY)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2026)Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bioventus (NASDAQ:BVS)

2. Amneal Pharmaceuticals (NASDAQ:AMRX)

3. Aveanna Healthcare Holdings (NASDAQ:AVAH)

1. Novabay Pharmaceuticals (NYSEMKT:NBY)

2. Dominari Holdings (NASDAQ:DOMH)

3. Spok Holdings (NASDAQ:SPOK)

1. Embecta (NASDAQ:EMBC)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Harmony Biosciences Holdings (NASDAQ:HRMY)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.